Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT1 | P04628 | 15/20 | 0.53 |
| ▸ | TGFBR1 | P36897 | 12/20 | 0.53 |
| ▸ | CLK2 | P49760 | 4/20 | 0.39 |
| ▸ | CLK3 | P49761 | 4/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17566547 | 0.88 | WNT1 (0.62) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17595833 | 0.87 | WNT1 (0.54) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17575492 | 0.81 | WNT1 (0.53) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17597990 | 0.79 | WNT1 (0.45) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL15371439 | 0.79 | WNT1 (0.64) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL18438639 | 0.79 | WNT1 (0.63) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17566553 | 0.79 | WNT1 (0.59) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17566110 | 0.79 | WNT1 (0.81) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL17566542 | 0.79 | WNT1 (0.63) | WNT1TGFBR1CLK2CLK3DYRK1A | |
| SCHEMBL18380530 | 0.78 | WNT1 (0.53) | WNT1TGFBR1CLK2CLK3DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016040180-A1 | 3-(1H-BENZO[D]IMIDAZOL-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF | SAMUMED, LLC (US) | 2016-03-17 | — | — | WO | claimed |